Clincosm LogoSign in Get a demo

metastatic esophageal squamous cell carcinoma

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • LDRT+CFRT
  • +2 more
  • Shanghai, China
  • +1 more
Aug 3, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai (Radiotherapy)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Radiotherapy
  • Shanghai, China
    Fudan University Shanghai cancer center
Feb 27, 2023

Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction

Active, not recruiting
Has Results
  • Metastatic Esophageal Adenocarcinoma
  • +7 more
  • Cixutumumab
  • +3 more
  • Scottsdale, Arizona
  • +232 more
Nov 16, 2022

Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy concurrent with capecitabine
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer center
Aug 21, 2022

Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Cisplatin)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Louisville, Kentucky
  • +91 more
Mar 30, 2022

ICIs Plus Chemotherapy for Advanced ESCC.

Active, not recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Anti-PD-1 Immune Checkpoint Inhibitors
  • Bengbu, Anhui, China
  • +22 more
Nov 21, 2021

Esophageal Tumor, Metastatic Esophageal Squamous Cell Carcinoma Trial in Taipei (Avelumab)

Enrolling by invitation
  • Esophageal Tumor
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital, Taiwan
Sep 6, 2021

Metastatic Esophageal Squamous Cell Carcinoma

Completed
  • Metastatic Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Apr 7, 2013